As the incidence rate of autism continues to grow, institutions and scientists are missing an incredible opportunity to study a unique and distinct demographic of the autism community: children of color. Not only does this complicate any mission of advancing the science of autism overall, but it perpetuates health disparities for African-American children with autism.
The crisis of Ebola virus disease in West Africa, at this writing, continues to deepen, with the World Health Organization now reporting more than 3,600 cases, and deaths exceeding 1,800. And yet, despite the headlines and the notes of alarm, Ebola as a research topic remains a comparatively limited presence in the scientific literature.
As I looked over the bios provided on NRC's webpage, I quickly realized that the Council appears to have a pretty poor idea of how to carry out such a challenging, complex and multifaceted study. In fact, this week 67 scientists and researchers publicly rebuked the NRC for failing, right at the outset, to put together a slate of experts equipped for the task.
The Intellectual Property and Science business of Thomson Reuters has released a new report, "The World's Most Influential Scientific Minds 2014," a listing of authors who have written multiple highly cited reports and have thereby demonstrated that their work is central to ongoing research in their respective fields.
How did we become the world's leading economy and one of its wealthiest nations per capita? One critical reason is that the U.S. has always invested in innovation. We spend more than any other country on R&D. Has this spending made us richer? The clear answer comes from a long run of economists who have studied this subject intensively. Here is what they have learned.